歡迎光臨源葉生物,登錄 | 注冊 |
當前位置: 首頁 > 小分子抑制劑 > Endocrinology/Hormones > GW9508

瀏覽歷史

S51531

GW9508

源葉(MedMol) 98%
  • 英文名:
  • 3-(4-((3-phenoxybenzyl)amino)phenyl)propanoic acid
  • 別名:
  • GW9508; GW-9508; GW 9508
  • CAS號:
  • 885101-89-3
  • 分子式:
  • C22H21NO3
  • 分子量:
  • 347.41
  • MDL:
  • MFCD09753282
  • 核磁/質(zhì)譜:
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
源葉(MedMol) S51531-10mg 98% ¥320.00元 5 0 0 0 EA 加入購物車
源葉(MedMol) S51531-50mg 98% ¥960.00元 4 0 0 0 EA 加入購物車
源葉(MedMol) S51531-100mg 98% ¥1480.00元 預計交期:2-3天 0 0 0 EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權(quán)與保護申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻

質(zhì)檢證書(COA)

摩爾濃度計算器

相關(guān)產(chǎn)品

  • 產(chǎn)品描述: GW9508 is a potent and selective G protein-coupled receptors FFA1 (GPR40) and GPR120 agonist with pEC50s of 7.32 and 5.46, respectively. GW9508 shows ~100-fold selectivity for GPR40 over GPR120. GW9508 is inactive against other GPCRs, kinases, proteases, integrins and PPARs. GW9508 is a glucose-sensitive insulin secretagogue and an ATP-sensitive potassium (KATP) channels opener. Anti-inflammatory and anti-atherosclerotic activities
  • 靶點: pEC50: 7.32 (GPR40) and 5.46 (GPR120);GPR;PotassiumChannel
  • 體外研究:
    GW9508 stimulates intracellular Ca2+ mobilization in HEK-293 cells expressing GPR40 (pEC50 of 7.32) or GPR120 (pEC50 of 5.46), but not in the parent HEK-293 cell line.
    GW9508 produces a concentration-dependent increase (pEC50 of 6.14) in glucose-stimulated insulin secretion at high glucose levels (25?mM). This resulted in a 1.52-fold increase in insulin secretion with 20?μM GW9508 in the presence of 25?mM glucose, compared with 25?mM glucose alone. The ability of GW9508 (10?μM) to enhance insulin secretion from MIN6 cells is significantly enhanced as glucose concentrations are increased.
    GW9508 inhibits CCL17 and CCL5 expression in a pertussis toxin-sensitive manner. The inhibitory effect by GW9508 is abrogated by depletion of GPR40 with RNA interference. GW9508 further suppresses expression of IL-11, IL-24, and IL-33 induced in HaCaT cells by TNF-α and IFN-γ. GW9508 also inhibits CCL5 and CXCL10 production by normal human epidermal keratinocytes.
  • 體內(nèi)研究:
    Administration of GW9508 200 (μM) topically to the skin suppresses ear swelling in a repeated hapten application model (BALB/c and C57BL/6 mice) and contact hypersensitivity with downregulation of CCL5 and CXCL10, respectively.
  • 參考文獻:
    1. Briscoe CP, et al. Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules. Br J Pharmacol. 2006 Jul;148(5):619-28. 2. Fujita T, et al. A GPR40 agonist GW9508 suppresses CCL5, CCL17, and CXCL10 induction in keratinocytes and attenuates cutaneous immune inflammation. J Invest Dermatol, 2011, 131(8), 1660-1667. 3. Zhao YF, et al. Activation of ATP-sensitive potassium channels in rat pancreatic beta-cells by linoleic acid through both intracellular metabolites and membrane receptor signalling pathway. J Endocrinol, 2008, 198(3), 533-540. 4. Suski M, et al. Anti-atherosclerotic action of GW9508 - Free fatty acid receptors activator - In apoE-knockout mice. Pharmacol Rep. 2019 Aug;71(4):551-555.
  • 溶解性: Soluble  in  DMSO
  • 保存條件: 2-8℃
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 2.878 ml 14.392 ml 28.784 ml
    5 mM 0.576 ml 2.878 ml 5.757 ml
    10 mM 0.288 ml 1.439 ml 2.878 ml
    50 mM 0.058 ml 0.288 ml 0.576 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。